Phosphorylation of VE-cadherin at Y685 by Src activation is required for eNOS-induced vascular barrier disruption in retinopathy (49) and angiotensin II–induced pulmonary microvascular endothelial barrier injury (50). Here, SRC is linked to retinal disorder.